ARS Investment Partners’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
GKFF
GS
RHJA
ARS Investment Partners's ASPN Position: Q1 2026 in Review
ARS Investment Partners sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 40,765 shares — an estimated $115K sold.
ARS Investment Partners first reported a position in ASPN in Q2 2021 and held it in 19 quarters. The position peaked at $784K in Q4 2021. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.
- ARS Investment Partners reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
- ARS Investment Partners sold 40,765 Aspen Aerogels shares in Q1 2026, an estimated $115K.
- ARS Investment Partners first reported a position in Aspen Aerogels in Q2 2021 and held it in 19 quarters.
- ARS Investment Partners's Aspen Aerogels position peaked at $784K in Q4 2021.
- 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.
Based on ARS Investment Partners's 13F filing for Q1 2026, filed 16 Apr 2026.